You or a loved one has just been diagnosed with a subtype of myeloproliferative neoplasms or MPN, but what does that mean? Is it essential thrombocythemia, polycythemia vera, or myelofibrosis? What treatment options are out there for you, especially if you don’t have access to an MPN specialist?

Top specialist Dr. Ruben Mesa answers key questions here in understandable language, not the usual medical jargon we see and hear online. For more on MPNs, please visit → https://www.thepatientstory.com/cance...

Featuring:
Dr. Ruben Mesa
Executive Director of Mays Cancer Center
Director of UT Health San Antonio MD Anderson Cancer Center
Myeloproliferative Neoplasms (MPNs) Specialist

In this Series: Dr. Mesa covers the latest updates focused on MPNs following the biggest blood cancer/disease conference (ASH) held at the end of 2021 that looked forward to emerging treatments studied in 2022 and beyond.

Videos:
1) Essential Thrombocythemia Updates for Patients and Caregivers (2022):    • Essential Thrombocythemia: What Patie...  
2) Polycythemia Vera: Latest Updates for Patients & Caregivers in 2022:    • Polycythemia Vera: Latest Updates for...  
3) For Myelofibrosis Patients: The Latest on Promising Treatments from Top Specialist:    • For Myelofibrosis Patients: The Lates...  

The interview has only been edited for clarity.

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
____________________________

#ThePatientStory #bloodcancer #blooddisease #hematology #oncology #MPN #myeloproliferativeneoplasms #essentialthrombocythemia #polycythemiavera #clinicaltrials #relapsedrefractory #Patientcare #cancertreatment #Cartcelltherapy